Deodato, Francesco
 Distribuzione geografica
Continente #
EU - Europa 5.794
NA - Nord America 5.306
AS - Asia 2.294
SA - Sud America 219
AF - Africa 73
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.704
Nazione #
US - Stati Uniti d'America 5.224
DE - Germania 2.352
SE - Svezia 1.155
SG - Singapore 869
CN - Cina 793
IT - Italia 543
UA - Ucraina 500
FR - Francia 286
IE - Irlanda 271
IN - India 210
GB - Regno Unito 206
BR - Brasile 192
ID - Indonesia 171
FI - Finlandia 157
RU - Federazione Russa 103
TR - Turchia 74
CA - Canada 72
BE - Belgio 49
CI - Costa d'Avorio 49
NL - Olanda 35
HK - Hong Kong 32
IR - Iran 32
JP - Giappone 32
CZ - Repubblica Ceca 28
VN - Vietnam 19
AT - Austria 13
ES - Italia 13
CH - Svizzera 12
LT - Lituania 11
RO - Romania 11
EG - Egitto 10
AR - Argentina 8
AU - Australia 8
CL - Cile 7
MA - Marocco 7
PL - Polonia 6
AM - Armenia 5
DK - Danimarca 5
EU - Europa 5
GR - Grecia 5
IL - Israele 5
KZ - Kazakistan 5
LK - Sri Lanka 5
PT - Portogallo 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
EC - Ecuador 4
PE - Perù 4
PH - Filippine 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
BG - Bulgaria 3
HR - Croazia 3
HU - Ungheria 3
IQ - Iraq 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MX - Messico 3
NO - Norvegia 3
NP - Nepal 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BO - Bolivia 2
CO - Colombia 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
TN - Tunisia 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AL - Albania 1
BZ - Belize 1
CR - Costa Rica 1
EE - Estonia 1
KE - Kenya 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 13.704
Città #
Chandler 1.233
Singapore 519
Ashburn 385
Jacksonville 286
Dublin 268
San Mateo 258
Nanjing 179
Wilmington 171
Jakarta 169
Dearborn 160
Boston 125
Bremen 125
The Dalles 121
Nürnberg 114
Milan 113
New York 104
Woodbridge 103
Beijing 97
Marseille 97
Ann Arbor 96
Lawrence 81
Cattolica 79
Princeton 77
Hyderabad 71
Izmir 68
Moscow 67
Helsinki 65
Los Angeles 65
Nanchang 65
Fairfield 60
Houston 56
Redwood City 55
Rome 55
Abidjan 49
Brussels 49
Munich 48
Seattle 47
Toronto 35
Leawood 33
University Park 33
Zhengzhou 33
Frankfurt am Main 32
Fremont 31
Kunming 31
Shenyang 31
Augusta 30
Düsseldorf 30
Phoenixville 29
Norwalk 28
Redmond 28
Hebei 26
Mountain View 24
Boardman 23
Jiaxing 23
Guangzhou 22
São Paulo 22
Tianjin 22
Lancaster 21
North York 21
Shanghai 21
Detroit 20
Auburn Hills 19
Changsha 19
Falls Church 19
Hong Kong 18
Pune 18
Cambridge 17
Hangzhou 17
Hanoi 14
Lauterbourg 14
Nuremberg 14
Brno 13
Chicago 13
London 13
Amsterdam 12
Andover 11
Monmouth Junction 11
Ardabil 10
Berlin 10
Edinburgh 10
Lanzhou 10
Portsmouth 10
Washington 10
Falkenstein 9
Hefei 9
Bologna 8
Cairo 8
Kish 8
Sacramento 8
Vienna 8
Central District 7
Indiana 7
Ningbo 7
Ottawa 7
Rio de Janeiro 7
San Francisco 7
Tokyo 7
Bari 6
Chengdu 6
Florence 6
Totale 6.856
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 258
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 177
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 155
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 153
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 153
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 149
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 147
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 145
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 144
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 144
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 140
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 140
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 139
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 139
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 138
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 136
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 136
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 136
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 135
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 134
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 132
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 131
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 131
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 131
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 131
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 127
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 126
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 124
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 124
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 123
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 122
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 121
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 120
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 119
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 119
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 118
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 117
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 117
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 116
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 116
In Vivo Portal Dosimetry by an Ionization Chamber 113
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 110
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 109
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 108
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 106
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 105
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 104
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 104
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 103
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 102
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 102
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 102
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 101
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 101
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 99
Real time transit dosimetry for the breath-hold radiotherapy technique experience 96
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 96
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 96
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 95
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 94
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 94
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 93
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 91
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 90
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 89
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 89
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 89
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 88
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 87
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 87
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 86
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 86
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 85
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 85
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 85
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 84
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 84
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 83
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 83
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 81
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 78
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 77
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 76
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 76
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 75
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 75
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 75
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 73
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 72
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 72
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 72
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 71
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 70
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 69
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 68
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 68
Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer 68
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 67
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 66
Advanced head and neck cancer in older adults: Results of a short course accelerated radiotherapy trial 66
Totale 10.682
Categoria #
all - tutte 62.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.276


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020314 0 0 0 0 0 0 0 0 0 0 213 101
2020/2021948 34 98 16 94 139 44 108 27 128 70 155 35
2021/20221.513 139 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.424 66 422 57 110 38 158 92 118 13 44 193 113
2024/20252.102 73 80 208 112 348 76 58 154 527 357 109 0
Totale 13.874